Login / Signup

Fifteen days in December: capture and analysis of Omicron-related travel restrictions.

Jordan SchermerhornAlaina CaseEllie GraedenJustin KerrMackenzie MooreSiobhan Robinson-MarshallTrae WallaceEmily WoodrowRebecca Katz
Published in: BMJ global health (2022)
Following the identification of the Omicron variant of the SARS-CoV-2 virus in late November 2021, governments worldwide took actions intended to minimise the impact of the new variant within their borders. Despite guidance from the WHO advising a risk-based approach, many rapidly implemented stringent policies focused on travel restrictions. In this paper, we capture 221 national-level travel policies issued during the 3 weeks following publicisation of the Omicron variant. We characterise policies based on whether they target travellers from specific countries or focus more broadly on enhanced screening, and explore differences in approaches at the regional level. We find that initial reactions almost universally focused on entry bans and flight suspensions from Southern Africa, and that policies continued to target travel from these countries even after community transmission of the Omicron variant was detected elsewhere in the world. While layered testing and quarantine requirements were implemented by some countries later in this 3-week period, these enhanced screening policies were rarely the first response. The timing and conditionality of quarantine and testing requirements were not coordinated between countries or regions, creating logistical complications and burdening travellers with costs. Overall, response measures were rarely tied to specific criteria or adapted to match the unique epidemiology of the new variant.
Keyphrases
  • public health
  • sars cov
  • risk factors
  • healthcare
  • clinical trial
  • infectious diseases
  • quality improvement
  • gestational age
  • bioinformatics analysis
  • placebo controlled